Wondering if ICON is quietly trading below what it is really worth, especially after a choppy few years in healthcare stocks? This breakdown will help you decide if it deserves a spot on your ...

Solutions Market Overview:The global electronic clinical outcome assessment (eCOA) solutions market is expected to grow at a ...

For Patrick Flanagan, CEO of Veristat, optimism will drive new financial growth.“The coming year will mark a new era of ...

Brooke Craig spent her sixth birthday in hospital during treatment for leukaemia this year and has set her sights on becoming ...

Virtual reality could offer a new way to treat winter depression, known as (SAD) says Anglia Ruskin University.

Is My Boss A Narcissist?' How Researchers Look And Listen For Clues. Between the public extravagances of today's business ...

If you’re now curious where to start, keep reading for a full breakdown of the best CurrentBody devices—including insights from Dr. Olstad, Newman, and dermatologist Dr. Ife Rodney —plus answers to ...

Detailed price information for Jupiter Neurosciences Inc (JUNS-Q) from The Globe and Mail including charting and trades.

Strike A Chord - an exclusive music and advocacy event highlighted the urgent need to restore women’s health research funding ...

DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced results of its latest industry survey, examining the challenges clinical trial sites ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...